Rentschler Biopharma to purchase US manufacturing site from Shire

Published: 18-Dec-2018
Manufacturing Finance Pharmaceutical

Under the terms of the agreement, Rentschler Biopharma will continue to manufacture product for Shire at the site

Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA, USA.

The development and manufacturing site will be leveraged as a CDMO by Rentschler Biopharma.

The closing of the transaction is subject to the prior satisfaction or waiver of certain closing conditions.

Financial terms of the transaction were not disclosed.

  • Companies:
  • Shire Pharmaceuticals
  • Rentschler Biopharma SE
See more

You may also like

Manufacturing

Rentschler Biopharma and Vetter unveil Xpert Alliance, a joint visualization of their successful strategic collaboration

Read more
The visualisation is designed to “bring to life” this ongoing alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing and expanding needs in the area of complex biopharmaceuticals

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
  3. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
  4. Naobios and Sumagen sign exclusive partnership to develop HIV vaccine Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Rentschler Biopharma and Vetter unveil Xpert Alliance, a joint visualization of their successful strategic collaboration

The visualisation is designed to “bring to life” this ongoing alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing and expanding needs in the area of complex biopharmaceuticals
Finance

Rentschler Biopharma supports construction of Einstein centre

To implement the project, the ‘First 11’ campaign aims to motivate more companies to become sponsors
Finance

Rentschler Biopharma breaks ground second Boston site

The design features upstream ballroom processing sized for production flexibility, while downstream processing suites are equipped with buffer storage and preparation space
Manufacturing

Rentschler Biopharma expands production of highly complex antibodies at German site

Manufacturing capacity for biopharmaceuticals is important benchmark for Germany as a biotechnology location, according to yesterday’s Biotech Report published by vfa bio and Boston Consulting Group
Finance

Vetter and Rentschler strengthen strategic alliance

The collaboration was initiated in 2020 with the intent to enable clients to bring their products to patients easier and faster
Manufacturing

Rentschler and Leukocare extend partnership with joint US site

The alliance has completed projects for companies around the globe since it was established in 2017
Drug Delivery

CureVac and Rentschler Biopharma ramp up vaccine manufacture

The companies aim to produce more than 100 million doses of the CureVac vaccine per year in Laupheim
Subscribe now